UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Icosabutate, a More Potent Form of Omega 3 Fatty Acids, Shows Promise in Lowering Triglycerides

Cardiology, 2016-01, Vol.135 (1), p.1-2

Riesen, Walter F.

2016

Volltextzugriff (PDF)

New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk

Wiener Klinische Wochenschrift, 2014-03, Vol.126 (5-6), p.169-175

2014

Volltextzugriff (PDF)

Performance evaluation of the Access FT3 and FT4 assays, comparison with Immulite and AxSym, and the relationship to TSH values

Clinical laboratory (Heidelberg), 2012-01, Vol.58 (7-8), p.645

2012

Volltextzugriff (PDF)

Commentary to factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis (1)

Atherosclerosis, 2010-02, Vol.208 (2), p.332-333

Riesen, Walter F

2010

Volltextzugriff (PDF)

Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk

European journal of preventive cardiology, 2016-02, Vol.23 (3), p.275-281

2016

Volltextzugriff (PDF)

Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults

Nephrology, dialysis, transplantation, 2007-04, Vol.22 (4), p.1107-1114

2007

Volltextzugriff (PDF)

Statin-induced immunomodulatory effects on human T cells in vivo

Atherosclerosis, 2004-07, Vol.175 (1), p.83-90

2004

Volltextzugriff (PDF)

Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers

Journal of hypertension, 2008-05, Vol.26 (5), p.871-877

2008

Volltextzugriff (PDF)

Pleiotropic Effects of Statins - What Is Their Clinical Significance?

Praxis (Bern. 1994), 2022-02, Vol.110 (2), p.86

Riesen, Walter F

2022

Volltextzugriff (PDF)

A new view of arteriosclerosis development points the way to new therapy concepts

Praxis (Bern. 1994), 2016-04, Vol.105 (8), p.427

Riesen, Walter F

2016

Volltextzugriff (PDF)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

European heart journal, 2020-01, Vol.41 (1), p.111-188

2020

Volltextzugriff (PDF)

Toward a more professional and practical medical education: a novel Central European approach

Advances in medical education and practice, 2015-01, Vol.6 (default), p.459-467

2015

Volltextzugriff (PDF)

High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study

Annals of internal medicine, 2002-04, Vol.136 (8), p.582

2002

Volltextzugriff (PDF)

Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial

BMC family practice, 2011-03, Vol.12, p.12

2011

Volltextzugriff (PDF)

Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination

Clinica chimica acta, 2008-04, Vol.390 (1), p.138-140

2008

Volltextzugriff (PDF)

Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia

Swiss medical weekly, 2008-07, Vol.138 (29-30), p.420

2008

Volltextzugriff (PDF)

Lipid-lowering therapy: strategies for improving compliance

Current medical research and opinion, 2004-01, Vol.20 (2), p.165-173

2004

Volltextzugriff (PDF)

CRP measured by a high sensitivity assay correlates with clinical probability (Wells score) testing for deep venous thrombosis

Thrombosis and haemostasis, 2004-04, Vol.91 (4), p.841

2004

Volltextzugriff (PDF)

Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study

Clinica chimica acta, 1999-11, Vol.289 (1), p.159-172

1999

Volltextzugriff (PDF)

Economic impact of hyperhomocysteinemia in Switzerland

Cardiovascular drugs and therapy, 2005-10, Vol.19 (5), p.365-369

2005

Volltextzugriff (PDF)

Comparability of Serum and Plasma Concentrations of Haemostasis Activation Markers

Clinical chemistry and laboratory medicine, 2001-07, Vol.39 (7), p.627-630

2001

Volltextzugriff (PDF)

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease

Swiss medical weekly, 2009-11, Vol.139 (45-46), p.646

Riesen, W F

2009

Volltextzugriff (PDF)

Statin treatment in primary and secondary prevention--a statement

Revue médicale suisse, 2014-12, Vol.10 (455), p.2430

2014

Volltextzugriff (PDF)

Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease

Clinical chemistry and laboratory medicine, 1998-11, Vol.36 (11), p.879-885

1998

Volltextzugriff (PDF)

Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients

The Journal of laboratory and clinical medicine, 2000-11, Vol.136 (5), p.379-389

2000

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(65)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(52)
Science & Technology
(46)
Life Sciences & Biomedicine
(44)
Biological And Medical Sciences
(26)
Male
(26)
Female
(24)
Middle Aged
(21)
Medical Sciences
(19)
Adult
(18)
Cardiovascular System & Cardiology
(15)
Risk Factors
(12)
Aged
(11)
Cardiac & Cardiovascular Systems
(11)
Medical Laboratory Technology
(11)
Peripheral Vascular Disease
(9)
Pharmacology. Drug Treatments
(9)
Cardiovascular System
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Chemistry And Laboratory Medicine
(6)
Atherosclerosis
(4)
Clinica Chimica Acta
(3)
Febs Letters
(3)
Journal Of Hypertension
(3)
Revue Médicale Suisse
(3)
Biochemistry
(2)
Clinical Chemistry
(2)
Praxis
(2)
Swiss Medical Weekly
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Icosabutate, a More Potent Form of Omega 3 Fatty Acids, Shows Promise in Lowering Triglycerides

New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk

Performance evaluation of the Access FT3 and FT4 assays, comparison with Immulite and AxSym, and the relationship to TSH values

Commentary to factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis (1)

Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk

Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults

Statin-induced immunomodulatory effects on human T cells in vivo

Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers

Pleiotropic Effects of Statins - What Is Their Clinical Significance?

A new view of arteriosclerosis development points the way to new therapy concepts

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Toward a more professional and practical medical education: a novel Central European approach

High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study

Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial

Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination

Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia

Lipid-lowering therapy: strategies for improving compliance

CRP measured by a high sensitivity assay correlates with clinical probability (Wells score) testing for deep venous thrombosis

Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study

Economic impact of hyperhomocysteinemia in Switzerland

Comparability of Serum and Plasma Concentrations of Haemostasis Activation Markers

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease

Statin treatment in primary and secondary prevention--a statement

Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease

Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients

Suchergebnisse filtern